Guillain-Barré syndrome (GBS) patients may worsen after initial treatment (treatment-related fluctuation [TRF]). It is difficult to distinguish GBS-TRF from chronic inflammatory demyelinating polyneuropathy with acute onset (A-CIDP). The authors compared 13 patients with A-CIDP with 11 patients with GBS-TRF and concluded that A-CIDP should be suspected when a patient with GBS deteriorates after 9 weeks from onset or when deterioration occurs three times or more. Maintenance treatment should then be considered. Copyright

doi.org/10.1212/01.wnl.0000167549.09664.b8, hdl.handle.net/1765/55454
Neurology
Department of Neurology

Ruts, L., van Koningsveld, R., & van Doorn, P. (2005). Distinguishing acute-onset CIDP from Guillain-Barré syndrome with treatment related fluctuations. Neurology, 65(1), 138–140. doi:10.1212/01.wnl.0000167549.09664.b8